Search research articles
Contact Us
Filters
Showing results (181-190 of 205) with videos related to
Page
of 21
Sort By:
The Oncologist
|
August 7, 2015
Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma
Lipika Goyal, Aparna Govindan, Rahul A Sheth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2020
Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI
Derek J Erstad, Mozhdeh Sojoodi, Martin S Taylor, et al.
Theranostics
|
September 30, 2024
Collagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studies
Shadi A Esfahani, Hua Ma, Shriya Krishna, et al.
Annals of Surgery
|
February 21, 2022
Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Versus the Standard of Care Imaging in the Diagnosis of Peritoneal Carcinomatosis
Felipe S Furtado, Mark Z Wu, Shadi A Esfahani, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 7, 2012
Melanoma
Daniel G Coit, Robert Andtbacka, Christopher J Anker, et al.
Journal of the National Cancer Institute
|
September 28, 2017
Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype
Theodore S Hong, Jennifer Y Wo, Darrell R Borger, et al.
JCI Insight
|
July 8, 2022
Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation
Emilie Crouchet, Shen Li, Mozhdeh Sojoodi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 2015
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Theodore S Hong, Jennifer Y Wo, Beow Y Yeap, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 10, 2019
Management implications of fluorodeoxyglucose positron emission tomography/magnetic resonance in untreated intrahepatic cholangiocarcinoma
Cristina Ferrone, Lipika Goyal, Motaz Qadan, et al.
Gut
|
March 29, 2020
Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma
Frank Jühling, Nourdine Hamdane, Emilie Crouchet, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 205) with videos related to
Sort By:
Page
of 21
The Oncologist
|
August 7, 2015
Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma
Lipika Goyal, Aparna Govindan, Rahul A Sheth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2020
Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI
Derek J Erstad, Mozhdeh Sojoodi, Martin S Taylor, et al.
Theranostics
|
September 30, 2024
Collagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studies
Shadi A Esfahani, Hua Ma, Shriya Krishna, et al.
Annals of Surgery
|
February 21, 2022
Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Versus the Standard of Care Imaging in the Diagnosis of Peritoneal Carcinomatosis
Felipe S Furtado, Mark Z Wu, Shadi A Esfahani, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 7, 2012
Melanoma
Daniel G Coit, Robert Andtbacka, Christopher J Anker, et al.
Journal of the National Cancer Institute
|
September 28, 2017
Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype
Theodore S Hong, Jennifer Y Wo, Darrell R Borger, et al.
JCI Insight
|
July 8, 2022
Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation
Emilie Crouchet, Shen Li, Mozhdeh Sojoodi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 2015
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Theodore S Hong, Jennifer Y Wo, Beow Y Yeap, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 10, 2019
Management implications of fluorodeoxyglucose positron emission tomography/magnetic resonance in untreated intrahepatic cholangiocarcinoma
Cristina Ferrone, Lipika Goyal, Motaz Qadan, et al.
Gut
|
March 29, 2020
Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma
Frank Jühling, Nourdine Hamdane, Emilie Crouchet, et al.
Page
of 21